Single-cell analysis reveals subtypes of colorectal tumors

March 20, 2017
Cancer — Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0

Combining single-cell genomics and computational techniques, a research team including Paul Robson, Ph.D., director of single-cell biology at The Jackson Laboratory (JAX), has defined cell-type composition of cancerous cells from 11 colorectal tumors, as well as adjacent noncancerous cells, a key to more targeted diagnosis and treatment.

"Using single-cell signatures," says JAX Research Scientist Elise Courtois, Ph.D., co-first author of a study published in Nature Genetics, "colorectal cancers can be further divided into subgroups based on cell-type composition of tumors. Because each of these subgroups has a different survival probability, our approach can provide oncologists with better information about prognosis and treatment options."

Advances in genomic sequencing have improved classification of tumor subtypes, guiding more precise cancer treatments and improving patient survival. However, tumors typically contain a variety of cancerous and noncancerous that all contribute to the biology of the tumor.

To date, gene expression in such tumors has been profiled using bulk transcriptome methods, providing a single transcriptome measure for what, in essence, represents many cell types. By employing single-cell transcriptomic technology it is now possible to deconstruct a tumor into its component cell-type parts and therefore gain a better understanding of the underlying biology.

Robson and co-senior authors Shyam Prabhakar, a computational biologist at the Genome Institute of Singapore, and Iain Beehuat Tan, a medical oncologist at the National Cancer Centre Singapore, led an effort that screened 626 randomly selected individual cells from the colorectal tumors and adjacent normal cell samples using single-cell RNA sequencing.

Computationally examining each cell's transcriptome (the readout of all the messenger RNA molecules in that cell) using their new algorithm, the researchers identified two distinct subtypes of cancer-associated fibroblasts (CAFs). These CAFs significantly contributed to the mesenchymal gene expression found in bulk tumor transcriptome data, a signature more often associated with a cancer cell process known as epithelial-mesenchymal transition. Their data make the case that CAFs contribute to a worse prognosis in colorectal cancer patients.

These findings, Robson notes, show promise for even more refined classification of colorectal and other tumors in the future. "And as the cost of single-cell transcriptomic analysis continues to drop, oncologists can access better tumor profiling to guide the treatment of patients," he says.

Explore further: Researchers use new computational method to define immune cell interactions

More information: Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors, Nature Genetics, nature.com/articles/doi:10.1038/ng.3818

Related Stories

Researchers use new computational method to define immune cell interactions

March 15, 2017
Immunotherapy, harnessing a patient's immune system to help fight cancer, has shown much promise as a potential cancer treatment. In a newly published study, a research team at Dartmouth-Hitchcock's Norris Cotton Cancer Center ...

Neuroscientists pinpoint key gene controlling tumor growth in brain cancers

March 9, 2017
Cedars-Sinai investigators have identified a stem cell-regulating gene that affects tumor growth in patients with brain cancer and can strongly influence survival rates of patients. The findings, published in the online edition ...

Silencing cancer cell communication may reduce the growth of tumors

January 30, 2017
In several types of cancer, elevated expression of the chemokine receptor CCR4 in tumors is associated with poor patient outcomes. Communication through CCR4 may be one mechanism that cancer cells use to create a pro-tumor ...

New genome-mapping technique opens new avenues for precision medicine

January 30, 2017
OHSU scientists have uncovered a method for quickly and efficiently mapping the genome of single cells within the body. Their findings, to be published Jan. 30 in the journal Nature Methods, clears the way for a significant ...

Researchers describe how tumors recruit and use stem cells to support tumor growth and progression

October 20, 2016
A new study has identified a mechanism used by tumors to recruit stem cells from bone and convert them into cancer-associated fibroblasts (CAFs) that facilitate tumor progression. This work, which pinpoints the specific biochemical ...

Metabolite that promotes cancer cell transformation and colorectal cancer spread identified

December 1, 2016
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial–mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring ...

Recommended for you

Vitamin C may encourage blood cancer stem cells to die

August 17, 2017
Vitamin C may "tell" faulty stem cells in the bone marrow to mature and die normally, instead of multiplying to cause blood cancers. This is the finding of a study led by researchers from Perlmutter Cancer Center at NYU Langone ...

Scientists develop novel immunotherapy technology for prostate cancer

August 17, 2017
A study led by scientists at The Wistar Institute describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific ...

Outdoor light at night linked with increased breast cancer risk in women

August 17, 2017
Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.